Brief: Valeant completes sale of Obagi Medical products business to Haitong International Zhongua Finance Acquisition Fund I, L.P.
Nov 10 (Reuters) - Valeant Pharmaceuticals International Inc
VRX.N VRX.TO :
* Valeant Pharmaceuticals completes sale of Obagi Medical
products
business to Haitong International Zhongua Finance Acquisition
Fund I, L.P.
Source text for Eikon: ID:nPn9S62wga
Further company coverage: VRX.N
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital